Peptide Vaccination in Combination With Azacitidine for Patients With MDS and AML

NCT02750995 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Myelodysplastic Syndrome
Acute Myeloid Leukemia

Interventions

BIOLOGICAL: NPMW-peptide vaccine
DRUG: Azacitidine

Sponsor

Daniel El Fassi

Collaborators

[object Object]